Valuation check: FIGS's profit margin is 8.72%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for FIGS is 8.72% as of June 2026. That compares with 1.26% in the prior-year period — up 591.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Figs's historical trend and sector peers before judging valuation or financial health.
Over the past year, FIGS's profit margin moved from 1.26% to 8.72% — a 591.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Figs's valuation or profitability profile.
Against Healthcare companies, FIGS currently prints 8.72% for profit margin, while the sector average sits near 21.34%. That is roughly 59.1% below the sector mean. Large gaps often invite a closer look at Figs's growth, margins, and balance sheet.
Profit Margin shows how effectively Figs converts resources into returns. At 8.72%, FIGS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 1.26% in the prior-year period — up 591.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting FIGS's profit margin (8.72%), review year-over-year change from 1.26%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.